Trulieve debuts on NYSE

Story updated 6/11/26

In a long awaited milestone for the licensed cannabis industry, Florida-based MSO Trulieve went public on the New York Stock Exchange. The move follows the Trump administration's rescheduling of MED to a schedule III substance under the Controlled Substances Act, and comes weeks before DEA hearings are set to begin on rescheduling REC.

Trulieve CEO Kim Rivers has gained a reputation as the industry's "Trump whisperer." The . . .